Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C. Turner, Alistair Ring, Peter Stephens et al.|The Lancet Oncology|2020Cited by 351
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Nicholas C. Turner, Paula Proszek et al.|Clinical Cancer Research|2019Cited by 137
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Nicholas C. Turner, Rosalind Cutts et al.|Nature Communications|2021Cited by 95
Pooled Sequencing of 531 Genes in Inflammatory Bowel Disease Identifies an Associated Rare Variant in BTNL2 and Implicates Other Immune Related GenesNatalie J. Prescott, Christopher G. Mathew, Benjamin Lehne et al.|PLoS Genetics|2015Cited by 63